UniPharma Co., Ltd.
TWO: 6621.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jen Chen
- Employees
- 30
- Headquarters
- Taipei, Taiwan
- IPO year
- 2017
- Market cap
- NT$437.9M
- Website
- https://www.uni-pharma.com
Loading 6621…
Loading profile data…Frequently asked questions about 6621
What does UniPharma Co., Ltd. (6621.TWO) do?
UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. The company provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. It offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa...
Where does 6621.TWO trade?
UniPharma Co., Ltd. (6621.TWO) trades on the Taipei Exchange.
What sector is 6621.TWO in?
UniPharma Co., Ltd. (6621.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of UniPharma Co., Ltd.?
Jen Chen is the chief executive officer of UniPharma Co., Ltd. (6621.TWO).
Where is UniPharma Co., Ltd. headquartered?
UniPharma Co., Ltd. is headquartered in Taiwan.
Does 6621.TWO pay a dividend?
UniPharma Co., Ltd. (6621.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6621.TWO go public?
UniPharma Co., Ltd. (6621.TWO) completed its initial public offering in 2017.